CurifyLabs is offering an absolute new innovative approach to compounding. We have created a technology called MiniLab to make high-quality 3D printing of personalized medicines available on site in pharmacies. Our offering brings industry level standards to mass customisation of medicines and the impact of CurifyLabs technology is better patient safety and efficacy at significantly lower cost. CurifyLabs’ is able to offer a more cost-effective and flexible solution to manual compounding and today CurifyLabs serves pharmacies on several European markets. The technology is based on over 10 years of academic research conducted by Professor Niklas Sandler Topelius.